Search results for "Anticoagulant therapy"
Adding aspirin or NSAID to anticoagulant doubles bleeding risk
Taking aspirin or an NSAID while on anticoagulant therapy significantly increases the risk of bleeding in patients who have had a venous thromboembolism (VTE), a recent study found.
https://immattersacp.org/weekly/archives/2014/04/22/5.htm
22 Apr 2014
Meta-analysis compares treatments for stroke prevention in afib
Risk for stroke or systemic embolism was lower with apixaban (5 mg twice daily), dabigatran (150 mg twice daily), edoxaban (60 mg twice daily), and rivaroxaban (20 mg twice daily) than warfarin, a study found.
https://immattersacp.org/weekly/archives/2017/12/05/1.htm
5 Dec 2017
Fixed-dose oral rivaroxaban appears noninferior to standard therapy for PE
Fixed-dose oral rivaroxaban is as effective as standard anticoagulant therapy for pulmonary embolism (PE) and may have a lower bleeding risk, a new study found.
https://immattersacp.org/weekly/archives/2012/03/27/5.htm
27 Mar 2012
ACP issues high-value care advice on evaluating hematuria
Among other recommendations, clinicians should include gross hematuria in their routine review of systems and specifically ask all patients with microscopic hematuria about any history of gross hematuria.
https://immattersacp.org/weekly/archives/2016/01/26/2.htm
26 Jan 2016
Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk
The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
https://immattersacp.org/weekly/archives/2016/11/22/6.htm
22 Nov 2016
MKSAP Quiz: evaluation for anticoagulation management
A 32-year-old woman is evaluated for anticoagulation management after an uncomplicated vaginal delivery of a healthy newborn. She was diagnosed with a bilateral pulmonary embolism at 25 weeks' gestation and was treated with therapeutic low-molecular-weight heparin (LMWH). The LMWH was discontinued at the onset of labor and was restarted 6 hours after delivery. Medical history is otherwise unremarkable, and her only medication is full-dose LMWH. Anticoagulation for 3 months is planned. The patient wishes to breastfeed her newborn. What is the most appropriate anticoagulation option for this patient?
https://immattersacp.org/weekly/archives/2016/02/23/3.htm
23 Feb 2016
Aspirin didn't reduce recurrent VTE but did reduce major vascular events
Low-dose aspirin may have therapeutic benefit for patients who have completed initial anticoagulant therapy for an unprovoked venous thromboembolism (VTE) even though the rate of recurrent VTE was not significantly reduced in a recent study.
https://immattersacp.org/weekly/archives/2012/11/13/1.htm
13 Nov 2012
MKSAP Quiz: referral for newly diagnosed hypertension
A 48-year-old man with newly diagnosed hypertension is referred for an echocardiogram to assess findings of left ventricular hypertrophy noted on the electrocardiogram. He is asymptomatic, and his medical history is unremarkable other than hypertension. His only medication is chlorthalidone. Following a physical exam, cardiac exam, and transthoracic echocardiogram, what is the most appropriate management based on this patient's echocardiographic findings?
https://immattersacp.org/weekly/archives/2015/11/10/3.htm
10 Nov 2015
Coding for anticoagulation as tricky as managing it
Diagnosis, lab tests and management make up the three key considerations when coding for anticoagulation management through Medicare. An expert sorts out the issues and scenarios for a variety of scenarios.
https://immattersacp.org/archives/2010/05/practice.htm
1 May 2010
More bleeds and clots in afib patients who took NSAIDs
Patients with atrial fibrillation who were prescribed NSAIDs had more serious bleeding and thromboembolic events than those not on NSAIDs, a new Danish study found.
https://immattersacp.org/weekly/archives/2014/11/18/1.htm
18 Nov 2014